Specialty Pharma Journal Specialty, Precision & Technology
Merck’s immunotherapy Keytruda (pembrolizumab) demonstrated positive results in three different cancers, including lung cancer, melanoma, and mesothelioma, according to presentations at the American Association for Cancer Research (AACR) conference in Philadelphia. At the cancer research meeting Sunday, Merck presented new Keytruda data, showing an overall response rate (ORR) of 19 …
Tag Archives: mesothelioma
April, 2015
-
15 April
AstraZeneca’s Investigational Mesothelioma Drug Receives Orphan Drug Status from the FDA
US health regulators have granted Orphan Drug designation to AstraZeneca’s investigational drug in development for treatment of a rare cancer. AstraZeneca announced that the US Food and Drug Administration (FDA) has granted orphan status for its anti-CTLA-4 monoclonal antibody, tremelimumab, for the treatment of malignant mesothelioma. The agency provides orphan …
March, 2015
-
26 March
FDA Grants Orphan Drug Designation to Aduro’s Mesothelioma Candidate
Today, Aduro Biotech Inc. announced that US health regulators have granted Orphan Drug designation to its novel, immuno-oncology candidate. The company said that the Office of Orphan Product Development of the US Food and Drug Administration (FDA) granted orphan drug designation to CRS-207, Aduro’s novel immuno-oncology product candidate in development …